相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ceramide Synthase 1 Inhibits Brain Metastasis of Non-Small Cell Lung Cancer by Interacting with USP14 and Downregulating the PI3K/AKT/mTOR Signaling Pathway
Yiquan Xu et al.
CANCERS (2023)
CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases
Ramin A. Morshed et al.
NEURO-ONCOLOGY ADVANCES (2023)
Review of Current Principles of the Diagnosis and Management of Brain Metastases
Alex W. Brenner et al.
FRONTIERS IN ONCOLOGY (2022)
The aberrant cancer metabolic gene carbohydrate sulfotransferase 11 promotes non-small cell lung cancer cell metastasis via dysregulation of ceruloplasmin and intracellular iron balance
Wei-Min Chang et al.
TRANSLATIONAL ONCOLOGY (2022)
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
Hamid Mithoowani et al.
CURRENT ONCOLOGY (2022)
Contribution of resident and circulating precursors to tumor-infiltrating CD8(+) T cell populations in lung cancer
Paul Gueguen et al.
SCIENCE IMMUNOLOGY (2021)
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
Clement Meiller et al.
GENOME MEDICINE (2021)
Risk of metastatic pheochromocytoma and paraganglioma in SDHx mutation carriers: a systematic review and updated meta-analysis
Hansong Lee et al.
JOURNAL OF MEDICAL GENETICS (2020)
Cancer Genome Evolutionary Trajectories in Metastasis
Nicolai J. Birkbak et al.
CANCER CELL (2020)
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma
Ayesha Noorani et al.
NATURE GENETICS (2020)
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non -randomised, open -label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2020)
Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons
Elisa Aquilanti et al.
NEUROSURGERY (2020)
Epidemiology of Brain Metastases
Patricia Sacks et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2020)
ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells
Yuanyuan Lei et al.
CELL DEATH & DISEASE (2020)
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
Won-Chul Lee et al.
GENOME BIOLOGY (2020)
STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
Simon Papillon-Cavanagh et al.
ESMO OPEN (2020)
The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
Leticia De Mattos-Arruda et al.
CELL REPORTS (2019)
Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036)
Hongsheng Wang et al.
CANCER (2019)
Quantitative evidence for early metastatic seeding in colorectal cancer
Zheng Hu et al.
NATURE GENETICS (2019)
Microenvironmental Heterogeneity in Brain Malignancies
Lucas J. M. Perus et al.
FRONTIERS IN IMMUNOLOGY (2019)
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial
Harriet M. Kluger et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Succinate dehydrogenase (SDH)-deficient neoplasia
Anthony J. Gill
HISTOPATHOLOGY (2018)
Iron and Cancer
Suzy V. Torti et al.
ANNUAL REVIEW OF NUTRITION, VOL 38 (2018)
Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration
Fanny Herisson et al.
NATURE NEUROSCIENCE (2018)
Evolution of Metastases in Space and Time under Immune Selection
Mihaela Angelova et al.
CELL (2018)
Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study
O. Kaidar-Person et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
Daniel N. Cagney et al.
NEURO-ONCOLOGY (2017)
What does PD-L1 positive or negative mean?
Antoni Ribas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2016)
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases
Elizabeth Dudnik et al.
LUNG CANCER (2016)
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K. Brastianos et al.
CANCER DISCOVERY (2015)
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Elza C. de Bruin et al.
SCIENCE (2014)
Brain metastases: epidemiology and pathophysiology
IT Gavrilovic et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
分享论文
